BIOMARIN PHARMACEUTICAL INC (BMRN)       112.2  -0.64 (-0.57%)

112.2  -0.64 (-0.57%)

US09061G1013 - Common Stock - After market: 112.2 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Registered users have access to more data. Please register or login for additional estimates.

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates


2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
1.704B
14.27%
1.861B
9.18%
1.846B
-0.76%
2.136B
15.69%
EBITDA
5.7M
108.77%
13.17M
131.05%
24.15M
83.37%
270.3M
1,019.25%
N/AN/AN/AN/A
EBIT
-99.6M
38.02%
-92M
7.63%
-83.889M
8.82%
158.59M
289.05%
Operating Margin
-5.85%-4.94%-4.54%7.42%
EPS
-0.15
72.73%
4.55
3,133.33%
-0.36
-107.91%
0.67
286.18%

All data in USD


Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates


Q3 / 22 Q4 / 22 Q1 / 23 Q2 / 23 Q3 / 23 Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25
EPS-0.01
95.67%
-0.07
77.41%
Revenue528.78M
29.37%
547.69M
21.76%
EBITDA74.601M57.331MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT13.455M
125.28%
-10.808M
83.59%
N/AN/AN/AN/AN/AN/AN/A

All data in USD


EPS and Revenue Surprises


Recent Earnings VS Estimates (USD)
Period Reported Estimate Difference Surprise Q3 2022 -0.04 -0.01 -0.03-361.36% Q2 2022 0.15 0.12 0.0329.99% Q1 2022 0.18 0.18 0.002.52% Q4 2021 -0.32 -0.33 0.012.37% Q3 2021 -0.20 -0.25 0.0520.94% Q2 2021 0.07 -0.12 0.19158.23% Q1 2021 0.09 -0.07 0.16231.05% Q4 2020 0.12 -0.19 0.31161.70%
Recent Revenue VS Estimates (USD)
Period Reported Estimate Difference Surprise Q3 2022 505.344M 528.78M -23.436M-4.43% Q2 2022 533.798M 531.9M 1.898M0.36% Q1 2022 519.359M 517.67M 1.689M0.33% Q4 2021 449.81M 451.23M -1.42M-0.31% Q3 2021 408.742M 444.03M -35.288M-7.95% Q2 2021 501.693M 457.47M 44.223M9.67% Q1 2021 486M 455.38M 30.62M6.72% Q4 2020 452.1M 449.03M 3.07M0.68%

EPS and Revenue Revisions


Next Q (1 month)Next Q (3 month)Next Year (1 month)Next Year (3 month)
EPS-1.26% -18.13% 0% -13.53%
Revenue-0.26% -0.53% 0% -0.11%